PCM
AGN.PRA

Palisade Capital Management’s Allergan plc AGN.PRA Stock Holding History

Palisade Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-21,502
Closed -$17.9M – 590
2016
Q2 		$17.9M Buy
21,502
+1,174
+6% +$981K 0.65% 32
2016
Q1 		$18.6M Buy
20,328
+1,024
+5% +$979K 0.61% 32
2015
Q4 		$19.8M Sell
19,304
-4,591
-19% -$4.61M 0.64% 29
2015
Q3 		$22.6M Buy
23,895
+1,166
+5% +$1.22M 0.67% 22
2015
Q2 		$23.7M Buy
+22,729
New +$23.8M 0.6% 26

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $86.6B AUM 38.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $92.2B AUM 15.8% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return